Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJD2A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $59,590
Award facts
- Contract value 100% obligated
- $59,589.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $59,589.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of DUPIXENT 300 mg/2 mL pens. This is a non-set-aside competitive award with an ultimate completion date of December 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. DUPIXENT (dupilumab) is a biologic medication used to treat various inflammatory conditions, including atopic dermatitis, asthma, and eosinophilic esophagitis, making it a critical pharmaceutical commodity for military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999,999,999 global pharmaceutical support vehicle running through December 2026. The prime IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen demonstrates consistent capability to meet federal medical procurement requirements through open competition across diverse therapeutic domains and delivery scales.
Quick answers
Who was awarded contract SPE2DR26FJD2A?
SPE2DR26FJD2A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26FJD2A worth?
The government has obligated $59,590 on SPE2DR26FJD2A.
Is contract SPE2DR26FJD2A an order under another contract?
Yes. SPE2DR26FJD2A is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJD2A competed?
The extent of competition for SPE2DR26FJD2A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award